GORE® TAG® Thoracic Branch Endoprosthesis
First-of-its kind FDA approved device designed for simplified, minimally invasive zone 2 TEVAR procedures. Maximize results without the potential risks and complexity of revascularization.
IDE Study outcomes. One year follow-up.
“The GORE® TAG® Thoracic Branch Endoprosthesis has the potential to simplify the treatment of Zone 2 LSA revascularization because it is a single device that can be used in a single procedure.”
Michael Dake, M.D.,
Co-national principal investigator
Senior Vice President, University of Arizona Health Services
“The GORE® TAG® Thoracic Branch Endoprosthesis has the potential to simplify the treatment of Zone 2 LSA revascularization because it is a single device that can be used in a single procedure.”
Michael Dake, M.D.,
Co-national principal investigator
Senior Vice President, University of Arizona Health Services
National Principal Investigators Himanshu Patel, M.D. and Michael Dake, M.D. share their perspectives on impact to LSA preservation procedures.
From pre-case planning to device procedural consultation, we are by your side to provide support.
- Training needs – Essential technical support with a deep reservoir of product knowledge.
- 8+ years – Average field representatives’ tenure supporting Gore's aortic devices, building on diverse clinical backgrounds.
- Non-commissioned sales force – Our focus is on outcomes.
Contact your Gore Field Sales Associate to learn more.
* For patients treated with TBE compared to those treated TEVAR and surgical LSA revascularization
- Squiers JJ, DiMaio JM, Schaffer JM, et al. Surgical debranching versus branched endografting in zone 2 thoracic endovascular aortic repair. Journal of Vascular Surgery 2022;75(6):1829-1836.e3.
- GORE® TAG® Thoracic Branch Endoprosthesis. [Instructions for Use]. Flagstaff, AZ: W. L. Gore & Associates, Inc. 2022; MD184153. Rev. 1
Featured Resources
Thoracic branch sizing guide
Pocket guide that provides sizes available and catalogue numbers for reference.
PDF, 597.7 KB
TBE Zone 2 Dissection Case Planning Form
For use in case planning with thoracic branch device
PDF, 209.88 KB
TBE Zone 2 Isolated Lesion Case Form
For use in case planning with thoracic branch device
PDF, 188.83 KB
Basic information about thoracic disease and treatment options for patients and their families
Overview of device, deployment, and primary benefits substantiated by data / outcomes for GORE® TAG® Thoracic Branch Endoprothesis.
How branch technology for zone 2 treatment impacted one patient's life.
INDICATIONS FOR USE IN THE U.S.: The GORE® TAG® Thoracic Branch Endoprosthesis is indicated for endovascular repair of lesions of the descending thoracic aorta, while maintaining flow into the left subclavian artery, in patients who are at high risk for debranching subclavian procedures and have: Adequate iliac/femoral access; Proximal Aortic Landing Zones: For Isolated Lesion Patients: Proximal landing zone cannot be aneurysmal, dissected, heavily calcified or heavily thrombosed; For Dissection Patients: Primary entry tear must be distal to the left subclavian artery and the proximal extent of the landing zone must not be dissected; Aortic inner diameter range 16-42 mm; Proximal segment length (length from distal edge of left subclavian artery to mid left common carotid ostium) of at least 2.0-4.0 cm, depending on Aortic Component selection; Proximal covered length (measured from distal edge of left subclavian artery to distal edge of left common carotid artery ostium) of at least 15–36 mm, depending on Aortic Component selection; For patients with prior ascending aorta or aortic arch repair with surgical graft: at least 2 cm landing zone proximal to the distal anastomosis; Left Subclavian Landing Zone: Landing zone cannot be aneurysmal, dissected, heavily thrombosed and severely tortuous (180 degree turn within the treated length); Left subclavian artery inner diameter of 6–18 mm, depending on Side Branch Portal diameter selected; Left subclavian artery minimum length of 2.5–3.0 cm, depending on Side Branch Portal diameter selected. Distal Landing Zone (Isolated Lesion Patients only): Outer curve length must be ≥ 2 cm proximal to celiac artery; Aortic inner diameter range 16-42 mm; Non aneurysmal, dissected, heavily calcified or heavily thrombosed landing zone; Native Aorta or previously placed GORE® TAG® Conformable Thoracic Stent Graft. CONTRAINDICATIONS: The GORE® TAG® Thoracic Branch Endoprosthesis is contraindicated in: Patients with known sensitivities or allergies to the device materials [ePTFE (polytetrafluoroethylene), FEP (fluoroethylpropylene), Nitinol (nickel, titanium), Gold, SB Component only - Heparin (CBAS® Heparin Surface)]; Patients who have a condition that threatens to infect the graft; Patients with known hypersensitivity to heparin, including those patients who have had a previous incident of Heparin-Induced Thrombocytopenia (HIT) type II. Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly
231000850-EN
